Recently, Pfizer announced that the company had ended its coronavirus vaccine trial with a 95 percent success rate. Moderna shortly followed with news that those who received two doses of the vaccine still had elevated levels of antibodies three months later. This is news that we have waited on for almost a year, and it is most certainly cause for hope and celebration –– we finally have the means to quell the virus that governs our lives.
However, that doesn’t mean that we can relax and resume our lives as usual. It’s dangerous to succumb to the boredom and agitation that makes us complacent and impulsive. We cannot forget that contracting the virus can mean life or death.